Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCNA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACTN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYO6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GPSM2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDS5A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EXOSC8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTP4A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BICC1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RRP7BP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HMMR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALDH18A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LSM14A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIF23 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PBK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLTSCR1L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SAFB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NR2F2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAD21 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KCTD9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on